Charles River Laboratories Other Operating Income or Expenses 2010-2025 | CRL

Charles River Laboratories annual/quarterly other operating income or expenses history and growth rate from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Charles River Laboratories other operating income or expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Charles River Laboratories other operating income or expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Charles River Laboratories annual other operating income or expenses for 2024 were $0B, a 0% decline from 2023.
  • Charles River Laboratories annual other operating income or expenses for 2023 were $0B, a 0% decline from 2022.
  • Charles River Laboratories annual other operating income or expenses for 2022 were $0B, a 0% decline from 2021.
Charles River Laboratories Annual Other Operating Income or Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $-7
2010 $-121
2009 $0
Charles River Laboratories Quarterly Other Operating Income or Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31 $-91
2010-09-30 $-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Services $8.765B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $148.115B 27.47
CVS Health (CVS) United States $75.901B 9.43
Elevance Health (ELV) United States $65.016B 8.74
Cencora (COR) United States $56.164B 19.54
DiDi Global (DIDIY) China $25.650B 27.25
Labcorp Holdings (LH) United States $21.906B 17.29
Natera (NTRA) United States $18.548B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.156B 0.00
ICON (ICLR) Ireland $14.957B 14.39
CochLear (CHEOY) Australia $13.609B 0.00
Solventum (SOLV) United States $12.725B 13.47
Medpace Holdings (MEDP) United States $12.583B 33.30
Revvity (RVTY) United States $11.135B 19.32
Viatris (VTRS) United States $10.786B 3.71
Avantor (AVTR) United States $9.547B 13.87
Sonic Healthcare (SKHHY) Australia $9.074B 0.00
HealthEquity (HQY) United States $8.282B 36.28
Caris Life Sciences,�Inc (CAI) United States $7.001B 0.00
Bausch + Lomb (BLCO) Canada $5.183B 30.52
Amplifon S.p.A (AMFPF) Italy $5.058B 27.69
BrightSpring Health Services (BTSG) United States $3.534B 32.42
Sotera Health (SHC) United States $3.446B 19.58
Surgery Partners (SGRY) United States $2.862B 37.22
Organon (OGN) United States $2.636B 2.80
GeneDx Holdings (WGS) United States $2.619B 60.38
Concentras Parent (CON) United States $2.589B 14.96
Alignment Healthcare (ALHC) United States $2.331B 0.00
Progyny (PGNY) United States $1.957B 43.08
PACS (PACS) United States $1.757B 0.00
Premier (PINC) United States $1.749B 13.27
GoodRx Holdings (GDRX) United States $1.739B 34.79
Ardent Health (ARDT) United States $1.532B 6.53
Teladoc Health (TDOC) United States $1.321B 0.00
Establishment Labs Holdings (ESTA) $1.192B 0.00
Pediatrix Medical (MD) United States $1.088B 8.28
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.875B 300.00
Agilon Health (AGL) United States $0.799B 0.00
AMN Healthcare Services Inc (AMN) United States $0.740B 6.93
CareDx (CDNA) United States $0.708B 11.06
Embecta (EMBC) United States $0.628B 4.23
So-Young (SY) China $0.507B 0.00
InnovAge Holding (INNV) United States $0.489B 0.00
Nutex Health (NUTX) United States $0.474B 7.18
Sonida Senior Living (SNDA) United States $0.469B 0.00
Omada Health (OMDA) $0.468B 0.00
LifeMD (LFMD) United States $0.464B 0.00
Auna S.A (AUNA) Luxembourg $0.456B 10.27
SBC Medicals (SBC) United States $0.454B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.401B 0.00
Enhabit (EHAB) United States $0.337B 27.75
Oncology Institute (TOI) United States $0.323B 0.00
Performant Healthcare (PHLT) United States $0.276B 0.00
Beauty Health (SKIN) United States $0.213B 0.00
DocGo (DCGO) United States $0.145B 23.67
Sera Prognostics (SERA) United States $0.109B 0.00
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
KindlyMD (NAKA) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.061B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.057B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.042B 0.00
Basel Medical Group (BMGL) Singapore $0.040B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Pheton Holdings (PTHL) China $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00